ATE240116T1 - Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie - Google Patents
Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämieInfo
- Publication number
- ATE240116T1 ATE240116T1 AT94112221T AT94112221T ATE240116T1 AT E240116 T1 ATE240116 T1 AT E240116T1 AT 94112221 T AT94112221 T AT 94112221T AT 94112221 T AT94112221 T AT 94112221T AT E240116 T1 ATE240116 T1 AT E240116T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- myeloidleukemia
- chronic
- treatment
- production
- Prior art date
Links
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 title abstract 3
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 title abstract 3
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 title 1
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 102000055647 human CSF2RB Human genes 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 101001054334 Homo sapiens Interferon beta Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL89662A IL89662A (en) | 1989-03-19 | 1989-03-19 | Pharmaceutical compositions comprising interferon-beta |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE240116T1 true ATE240116T1 (de) | 2003-05-15 |
Family
ID=11059803
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94112221T ATE240116T1 (de) | 1989-03-19 | 1990-03-15 | Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie |
| AT90104936T ATE157544T1 (de) | 1989-03-19 | 1990-03-15 | Verwendung von human-beta-interferon zur stimulierung der erythropoiesis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90104936T ATE157544T1 (de) | 1989-03-19 | 1990-03-15 | Verwendung von human-beta-interferon zur stimulierung der erythropoiesis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5104653A (de) |
| EP (2) | EP0643973B1 (de) |
| JP (1) | JP2883669B2 (de) |
| AT (2) | ATE240116T1 (de) |
| AU (1) | AU619960B2 (de) |
| CA (1) | CA2011992C (de) |
| DE (2) | DE69031355T2 (de) |
| DK (2) | DK0643973T3 (de) |
| ES (2) | ES2198409T3 (de) |
| GR (1) | GR3024763T3 (de) |
| IL (1) | IL89662A (de) |
| ZA (1) | ZA901994B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4128319A1 (de) * | 1991-08-27 | 1993-03-04 | Bioferon Biochem Substanz | Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen |
| US6242417B1 (en) | 1994-03-08 | 2001-06-05 | Somatogen, Inc. | Stabilized compositions containing hemoglobin |
| US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
| EP1759708A1 (de) * | 1995-07-25 | 2007-03-07 | Toray Industries, Inc. | IFN-beta zur Behandlung von krebs-verwandten Knochenerkrankungen |
| WO1999040106A2 (en) | 1998-02-09 | 1999-08-12 | University Of Southern California | Use of angiotensin analogues for promoting erythropoiesis |
| PL209928B1 (pl) * | 2000-11-07 | 2011-11-30 | Novartis Vaccines & Diagnostic | Kompozycja farmaceutyczna zawierająca biologicznie aktywny IFN-β i mannitol, wstępnie napełniona strzykawka zawierająca tę kompozycję oraz sposób wytwarzania preparatu IFN-β |
| DE60108661T2 (de) * | 2000-11-14 | 2006-01-05 | Université Libre de Bruxelles | Herstellung und verwendung von dendritischen zellen |
| US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| WO2004091495A2 (en) * | 2003-04-09 | 2004-10-28 | University Of Utah Research Foundation | Compositions and methods related to production of erythropoietin |
| AU2005211385B2 (en) | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
| WO2005107384A2 (en) * | 2004-03-31 | 2005-11-17 | Nitromed, Inc. | Methods for treating blood disorders with nitric oxide donor compounds |
| CA2634473A1 (en) * | 2006-02-17 | 2007-08-30 | Nitromed, Inc. | Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4460574A (en) * | 1980-06-16 | 1984-07-17 | Yabrov Alexander A | Prophylaxis or treatment of interferon-sensitive diseases |
| GB8412564D0 (en) * | 1984-05-17 | 1984-06-20 | Searle & Co | Structure and properties |
| CA1294215C (en) * | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| US4851219A (en) * | 1986-11-18 | 1989-07-25 | Genentech, Inc. | Method for the treatment of chronic myelogenous leukemia |
| AU2855189A (en) * | 1988-01-25 | 1989-07-27 | Baker Cummins Dermatologicals, Inc. | Method of treating fibrotic disorders |
-
1989
- 1989-03-19 IL IL89662A patent/IL89662A/xx active IP Right Grant
-
1990
- 1990-03-12 CA CA002011992A patent/CA2011992C/en not_active Expired - Lifetime
- 1990-03-15 ZA ZA901994A patent/ZA901994B/xx unknown
- 1990-03-15 EP EP94112221A patent/EP0643973B1/de not_active Expired - Lifetime
- 1990-03-15 EP EP90104936A patent/EP0388799B1/de not_active Expired - Lifetime
- 1990-03-15 AT AT94112221T patent/ATE240116T1/de not_active IP Right Cessation
- 1990-03-15 DK DK94112221T patent/DK0643973T3/da active
- 1990-03-15 DK DK90104936.1T patent/DK0388799T3/da active
- 1990-03-15 AT AT90104936T patent/ATE157544T1/de not_active IP Right Cessation
- 1990-03-15 ES ES94112221T patent/ES2198409T3/es not_active Expired - Lifetime
- 1990-03-15 DE DE69031355T patent/DE69031355T2/de not_active Expired - Lifetime
- 1990-03-15 DE DE69034076T patent/DE69034076T2/de not_active Expired - Lifetime
- 1990-03-15 ES ES90104936T patent/ES2107414T3/es not_active Expired - Lifetime
- 1990-03-16 AU AU51445/90A patent/AU619960B2/en not_active Expired
- 1990-03-16 US US07/495,027 patent/US5104653A/en not_active Expired - Lifetime
- 1990-03-19 JP JP2069519A patent/JP2883669B2/ja not_active Expired - Lifetime
-
1997
- 1997-09-17 GR GR970402418T patent/GR3024763T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0388799T3 (da) | 1998-03-30 |
| EP0643973A1 (de) | 1995-03-22 |
| DE69034076T2 (de) | 2003-11-20 |
| US5104653A (en) | 1992-04-14 |
| EP0643973B1 (de) | 2003-05-14 |
| DE69031355D1 (de) | 1997-10-09 |
| JP2883669B2 (ja) | 1999-04-19 |
| EP0388799A2 (de) | 1990-09-26 |
| DE69034076D1 (de) | 2003-06-18 |
| ES2107414T3 (es) | 1997-12-01 |
| EP0388799A3 (de) | 1991-07-31 |
| ES2198409T3 (es) | 2004-02-01 |
| CA2011992A1 (en) | 1990-09-19 |
| CA2011992C (en) | 2003-04-29 |
| AU5144590A (en) | 1990-09-20 |
| JPH0314523A (ja) | 1991-01-23 |
| AU619960B2 (en) | 1992-02-06 |
| DK0643973T3 (da) | 2003-09-08 |
| GR3024763T3 (en) | 1997-12-31 |
| IL89662A0 (en) | 1989-09-28 |
| IL89662A (en) | 1997-11-20 |
| EP0388799B1 (de) | 1997-09-03 |
| ZA901994B (en) | 1990-12-28 |
| DE69031355T2 (de) | 1998-01-08 |
| ATE157544T1 (de) | 1997-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3030703T3 (en) | Process for the production of biologically active protein (e.g. TGF) | |
| ATE135363T1 (de) | Nucleoside zur verwendung für die therapie | |
| ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
| DE59000270D1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
| ATE157251T1 (de) | Verwendung von inositoltriphosphat zur behandlung von entzündungen | |
| ATE240116T1 (de) | Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie | |
| UA45942A (uk) | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція | |
| DE3882775T2 (de) | Zusammensetzung zur Behandlung von parodontaler Krankheit. | |
| GR3025488T3 (en) | Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions | |
| DE3584560D1 (de) | Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen. | |
| ATE174798T1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
| ATE59780T1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
| ATE247474T1 (de) | Verwendung von inosittriphosphat zur herstellung von arzneimitteln | |
| ATE114468T1 (de) | Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs. | |
| NO873934D0 (no) | Fremgangsmaate for forbedret saarheling. | |
| ES2061496T3 (es) | Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante. | |
| ATE130194T1 (de) | Subkutane verabreichung des humanen choriongonadotropins. | |
| GR3004272T3 (de) | ||
| DE69118847D1 (de) | Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus | |
| ATE124264T1 (de) | Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen. | |
| ATE76571T1 (de) | Zusammensetzung zur behandlung der haut. | |
| ATE56360T1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0643973 Country of ref document: EP |
|
| EELA | Cancelled due to lapse of time |